Some estimates suggest discontinuation may reach 50 to 75% within the first year, depending on patient population and cost-sharing exposure
To this end, we often prescribe GLP-1 agonists, specifically Semaglutide GLP-1 and Liraglutide, due to their efficacy in reducing blood glucose levels and promoting weight loss
CLA can slightly reduce body fat in humans, but results vary
Studies have shown that chemicals can be released via gut bacteria, entering the bloodstream and reaching the skin
This is complemented by the incretin effect, insulin-sensitising properties, and promotion of subcutaneous fat accumulation mediated by GIP, as well as the thermogenic and lipolytic actions of GCG (Table 2).54 Its structure resists degradation by DPP-4 and enables binding to albumin, resulting in a half-life of six days, which allows for once-weekly subcutaneous administration
5.1 Urban-Centric Availability Most GLP-1 prescriptions and stock are concentrated in metros and Tier-1 cities where diabetologists and endocrinologists are based